• Fingolimod (FTY720): Mechanism and Research Use

  2026-08-25

  Fingolimod (FTY720) is an orally bioavailable sphingosine-1-phosphate receptor modulator used clinically for relapsing multiple sclerosis. Its best-established action is lymphocyte egress inhibition, while BDNF and ERK1/2 findings support separate neurobiological research applications.

• Gramine–CUL3–MTDH Ferroptosis in TNBC

  2026-08-24

  A 2026 reference study identifies Gramine as a mechanistically supported ferroptosis inducer in triple-negative breast cancer, acting through CUL3-mediated control of MTDH stability. Its combination of chemical-proteomic screening, target-engagement assays, genetic rescue, and mouse-model validation provides a framework for studying MTDH ubiquitination in cancer biology research.

• Mucocutaneous Candidiasis: Diagnosis and Treatment

  2026-08-24

  This 2009 clinical review integrates lesion classification, direct microscopy, risk-factor assessment, and treatment selection for cutaneous and oral candidiasis. Its most practical contribution is a diagnostic-and-management framework that distinguishes colonization from disease and links recurrence prevention to correction of local and systemic susceptibility factors.

• Hyaluronic acid sodium salt for Reliable Assays

  2026-08-23

  Learn how Hyaluronic acid sodium salt (SKU B8382) can be integrated into cell viability, proliferation, cytotoxicity, extracellular matrix, and nanoparticle workflows. This scenario-driven guide emphasizes assay controls, material handling, interpretation, and practical vendor-selection criteria.

• From lncRNA Mechanisms to Translational RT-qPCR

  2026-08-22

  A mechanistic and strategic guide to translating the PART1/miR-503-5p/FOXK1 ovarian cancer model into more reliable gene-expression workflows, with practical guidance on primer choice, complex RNA templates, controls, and the role of the HyperScript™ First-Strand cDNA Synthesis Kit.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-22

  FITC-Concanavalin A (ConA) Conjugate provides direct fluorescent detection of accessible α-D-glucose and α-D-mannose residues on cells and tissue sections. It is intended for carbohydrate-focused immunofluorescence staining, microscopy, and flow cytometry workflows, not for identifying non-carbohydrate targets or unvalidated assay formats.

• RQ3025 Broad-Spectrum Bivalent mRNA Vaccine Study

  2026-08-21

  The reference study evaluates RQ3025, a bivalent mRNA vaccine designed around recurrent SARS-CoV-2 spike mutations, across several animal models. Its broad neutralizing activity, variant protection, Th1-biased cellular response, and favorable histological profile support further development while remaining strictly preclinical evidence.

• Cyclic di-GMP, HipH, and Biofilm Persistence

  2026-08-20

  The 2024 eLife study identifies Cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Its findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for studying biofilm resilience beyond simple diffusion or nutrient-limitation models.

• BMP4-GPX4 Protects RGCs in NMDA Glaucoma Models

  2026-08-20

  Fang et al. identify a BMP4-GPX4 response associated with reduced ferroptotic stress and improved retinal stem cell differentiation after transplantation in an NMDA-induced high-intraocular-pressure glaucoma model. The work connects RGC preservation, iron-dependent oxidative injury, and regenerative cell therapy, while providing a multi-readout framework for studying retinal neurodegeneration.

• Isorhamnetin Activates PI3K/Akt in Oocyte Maturation

  2026-08-19

  The reference study shows that isorhamnetin improves porcine oocyte maturation by reducing oxidative, mitochondrial, apoptotic, and endoplasmic reticulum stress while activating PI3K/Akt signaling. Its integrated design connects polar body extrusion with molecular stress readouts, providing a useful framework for oxidative stress research while leaving human fertility translation unresolved.

• Drug Repurposing for CRISPR DNA Repair Control

  2026-08-19

  The reference study presents a large-scale repurposing screen showing that clinically approved drugs can shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. Its identification of ESR2 and AOX1 as pathway-relevant regulators, together with drug-induced synthetic lethality, creates a mechanistic framework for improving genome editing and exploring precision cancer vulnerabilities.

• Gramine Workflows for Ferroptosis Research

  2026-08-18

  Gramine provides a mechanism-guided way to study ferroptosis in triple-negative breast cancer models, linking CUL3 target engagement with MTDH regulation and downstream oxidative injury. This workflow combines dose-response screening, orthogonal binding assays, rescue experiments, and practical handling guidance for more reproducible cancer biology research.

• Degarelix Acetate: Assay Workflows and Optimization

  2026-08-18

  Degarelix acetate supports precise GnRH pathway interrogation, from receptor-linked hormone secretion assays to prostate cancer research models. Its additional value in formulation work is revealed by 1H NMR aggregation analysis, enabling researchers to separate pharmacology questions from peptide stability effects.

• (S)-(+)-Ibuprofen COX Inhibitor Workflow

  2026-08-17

  Build more reproducible inflammation assays with the pharmacologically active (S)-(+)-Ibuprofen enantiomer, from soluble stock preparation through COX-focused endpoint selection. The same compound also supports carefully controlled ecotoxicology and biodegradation studies, provided its environmental activity is interpreted separately from mammalian pharmacology.

• NMDA in Excitotoxicity and Ferroptosis Models

  2026-08-17

  NMDA (N-Methyl-D-aspartic acid) provides a controlled way to connect receptor-driven excitotoxicity with calcium dysregulation, oxidative stress, and ferroptosis. This article presents a phenotype-first workflow informed by a recent glaucoma study and explains how to select orthogonal assays for stronger mechanistic interpretation.

554 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page